311 related articles for article (PubMed ID: 10976477)
1. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy.
Bäz E; Madjar H; Reuss C; Vetter M; Hackelöer B; Holz K
Ultrasound Obstet Gynecol; 2000 May; 15(5):377-82. PubMed ID: 10976477
[TBL] [Abstract][Full Text] [Related]
2. [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers].
Aichinger U; Schulz-Wendtland R; Krämer S; Lell M; Bautz W
Rofo; 2002 Nov; 174(11):1395-401. PubMed ID: 12424666
[TBL] [Abstract][Full Text] [Related]
3. [Breast cancer recurrence versus scar. Ultrasonographic differentiation using Levovist as the contrast medium].
Stuhrmann M; Schwarz T; Schietzel M
Ultraschall Med; 2001 Feb; 22(1):2-6. PubMed ID: 11253551
[TBL] [Abstract][Full Text] [Related]
4. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography.
Stuhrmann M; Aronius R; Schietzel M
AJR Am J Roentgenol; 2000 Dec; 175(6):1585-9. PubMed ID: 11090380
[TBL] [Abstract][Full Text] [Related]
5. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity.
Svensson WE; Pandian AJ; Hashimoto H
Ultraschall Med; 2010 Oct; 31(5):466-74. PubMed ID: 20094978
[TBL] [Abstract][Full Text] [Related]
6. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
Kook SH; Kwag HJ
J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
[TBL] [Abstract][Full Text] [Related]
7. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?].
Grüner C; Schönwälder A; Schulz-Wendtland R; Lang N; Bautz W
Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578
[TBL] [Abstract][Full Text] [Related]
8. [Vascularization of breast tumors: use of ultrasound contrast medium in evaluating tumor entity. Preliminary results].
Stuhrmann M; Aronius R; Roefke C; Schietzel M
Rofo; 1998 Oct; 169(4):360-4. PubMed ID: 9819647
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography.
Zdemir A; Kiliç K; Ozdemir H; Yücel C; Andaç S; Colak M
J Ultrasound Med; 2004 Feb; 23(2):183-95; quiz 196-7. PubMed ID: 14992355
[TBL] [Abstract][Full Text] [Related]
10. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions].
Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA
Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504
[TBL] [Abstract][Full Text] [Related]
11. [Contrast enhanced power Doppler and color Doppler ultrasound in breast masses: Efficiency in diagnosis and contributions to differential diagnosis].
Algül A; Balci P; Seçil M; Canda T
Tani Girisim Radyol; 2003 Jun; 9(2):199-206. PubMed ID: 14661490
[TBL] [Abstract][Full Text] [Related]
12. Color Doppler sonography in the evaluation of palpable breast masses.
McNicholas MM; Mercer PM; Miller JC; McDermott EW; O'Higgins NJ; MacErlean DP
AJR Am J Roentgenol; 1993 Oct; 161(4):765-71. PubMed ID: 8372754
[TBL] [Abstract][Full Text] [Related]
13. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
Menna S; Di Virgilio MR; Burke P
Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
15. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.
Forsberg F; Kuruvilla B; Pascua MB; Chaudhari MH; Merton DA; Palazzo JP; Goldberg BB
Ultrasound Med Biol; 2008 Sep; 34(9):1365-72. PubMed ID: 18436369
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
17. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.
Moon WK; Im JG; Noh DY; Han MC
Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451
[TBL] [Abstract][Full Text] [Related]
18. Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent.
Blohmer JU; Reinhardt M; Schmalisch G; Lichtenegger W; Hausschild M; Kümmel S; Fischer T; Ohlinger R; Thomas A
Anticancer Res; 2006; 26(2C):1691-8. PubMed ID: 16617563
[TBL] [Abstract][Full Text] [Related]
19. Power Doppler and gray-scale sonography standardized by BI-RADS for the differentiation of benign postoperative lesion and local recurrence after breast-conserving therapy.
Kubota K; Iwasa H; Aoyama N; Hamada N; Nogami M; Tamura T; Nishioka A; Ogawa Y
Oncol Rep; 2011 Dec; 26(6):1357-62. PubMed ID: 21887473
[TBL] [Abstract][Full Text] [Related]
20. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress.
Kedar RP; Cosgrove D; McCready VR; Bamber JC; Carter ER
Radiology; 1996 Mar; 198(3):679-86. PubMed ID: 8628854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
